(Q24245945)

1

0 references

Dirk De Ruysscher

2

object named as

Dirk K M De Ruysscher

0 references

author name string

Ruud Houben

4

0 references

Isabelle Rutten

5

0 references

Johan F. Vansteenkiste

Cochrane Database of Systematic Reviews

6

0 references

publication date

18 October 2004

0 references

published in

0 references

cites work

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

Split-course versus continuous thoracic radiation therapy for limited-stage small-cell lung cancer: final report of a randomized phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

Clinical evidence for tumor clonogen regeneration: interpretations of the data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

Repopulation of tumour cells between cycles of chemotherapy: a neglected factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

Chest radiotherapy in limited-stage small cell lung cancer: facts, questions, prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

Clinical promise tempered by reality in the delivery of combined chemoradiation for common solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

Small cell lung cancer. State-of-the-art therapy 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

New chemotherapy agents for small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

The role of thoracic radiotherapy in the management of limited-stage small cell lung cancer: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

The treatment of limited small cell lung cancer: a report of the progress made and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

Time Between the First Day of Chemotherapy and the Last Day of Chest Radiation Is the Most Important Predictor of Survival in Limited-Disease Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

7 January 2021

Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

7 January 2021

Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

7 January 2021

Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004700.PUB2

7 January 2021